FDA Provides Draft Guidance on Refuse to Accept Policy for 510(k)s to Replace Existing Guidances

The FDA released a draft guidance, entitled “Refuse to Accept Policy for 510(k)s,” that seeks to clarify and ultimately replace existing policy documents explaining when a medical device premarket notification (510(k)) submission is administratively complete and ready for substantive review.
Lexology